| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/13/2011 | US20110009417 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009414 Heterocyclic derivatives and their use as therapeutic agents |
| 01/13/2011 | US20110009410 Apoptosis signal-regulating kinase inhibitors |
| 01/13/2011 | US20110009409 Dual-acting pyrazole antihypertensive agents |
| 01/13/2011 | US20110009399 Organic compounds |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009389 Imidazole derivative, their production and use |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009359 Use of non-digestible carbohydrates for improving intestinal microbiota |
| 01/13/2011 | US20110009347 Combination therapy for the treatment of diabetes |
| 01/13/2011 | US20110009325 Crystalline forms of rapamycin analogs |
| 01/13/2011 | US20110009322 Use of bradykinin and related b2r agonists to treat ocular hypertension and glaucoma |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | US20110009310 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008467 Sodium thiosulfate-containing pharmaceutical compositions |
| 01/13/2011 | US20110008432 Method for Treating a Patient in Need of Aspirin Therapy |
| 01/13/2011 | US20110008428 Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
| 01/13/2011 | US20110008408 Solid dosage form for treating headaches |
| 01/13/2011 | US20110008406 Silk Fibroin Hydrogels and Uses Thereof |
| 01/13/2011 | US20110008396 Compositions and methods for treating cardiovascular conditions |
| 01/13/2011 | US20110008367 Anti-vegf antibody |
| 01/13/2011 | US20110008366 Inhibition of versican with sirna and other molecules |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008359 Monoclonal antibodies against angptl4 |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008349 Hypoxia Induced Mitogenic Factor |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |
| 01/13/2011 | US20110008340 Anti-properdin antibodies |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008324 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 01/13/2011 | US20110008315 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 01/13/2011 | US20110008297 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 01/13/2011 | US20110008282 IL-1alpha immunization induces autoantibodies protective against atherosclerosis |
| 01/13/2011 | US20110008281 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 01/13/2011 | US20110008278 Modulators of paraptosis and related methods |
| 01/13/2011 | US20110008267 Pharmaceutical and Cosmeceutical Wash-Off Mousse Shampoo Compositions, Processes for Preparing the Same and Uses Thereof |
| 01/13/2011 | US20110008250 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008248 Peptide Antagonists of TGF-Beta Family Members and Therapeutic Uses Thereof |
| 01/13/2011 | US20110005960 Stable pharmaceutical compositions of carvedilol |
| 01/13/2011 | US20110005947 Inhibitors of jak |
| 01/13/2011 | CA2767825A1 Cardiac tissue-derived cells |
| 01/12/2011 | EP2272985A1 Antisense modulation of apolipoprotein (A) expression |
| 01/12/2011 | EP2272869A2 Angiopoietin-2 specific binding agents |
| 01/12/2011 | EP2272854A1 Novel glycolipid and use thereof |
| 01/12/2011 | EP2272848A1 Xanthine derivatives as selective HM74A agonists |
| 01/12/2011 | EP2272844A1 Five-membered ring compound |
| 01/12/2011 | EP2272843A1 Quinoline compound |
| 01/12/2011 | EP2272841A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 01/12/2011 | EP2272832A1 Phenylpropionic acid derivative and use thereof |
| 01/12/2011 | EP2272826A1 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them |
| 01/12/2011 | EP2272825A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation |
| 01/12/2011 | EP2272524A2 Y2 selective receptor agonists for therapeutic interventions |
| 01/12/2011 | EP2272513A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2272512A1 Pharmaceutical compositions for treating cancer |
| 01/12/2011 | EP2271646A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/12/2011 | EP2271643A1 Compounds |
| 01/12/2011 | EP2271631A2 Inhibitors of protein kinases |
| 01/12/2011 | EP2271628A1 Benzimidazole derivatives as calcium channel blockers |
| 01/12/2011 | EP2271617A1 Substituted 4-hydroxy-n- (4-hydroxyphenyl) indoles as estrogenic agents |
| 01/12/2011 | EP2271405A2 Nip thiazole derivatives as inhibitors of 11-beta-hydorxysteroid dehydrogenase-1 |
| 01/12/2011 | EP2190827B1 N-benzyl-n'-arylcarbonylpiperazine derivatives as lxr modulators |
| 01/12/2011 | EP2139866B1 Crystalline 1-(cyclohexyloxycarbonyloxy) ethyl 1-((2'-cyanobiphenyl-4-yl)methyl)-2-ethoxy-1h-benzo[d]imidazole-7-carboxylate and a process for its preparation |
| 01/12/2011 | EP2129368B1 Combination for use in the treatment of inflammatory disorders |
| 01/12/2011 | EP1439863B1 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 01/12/2011 | EP1402266B1 Reducing RISK OF COMPLICATIONS OF PREMATURITY |
| 01/12/2011 | EP1317186B1 Improved bioactive whey protein hydrolysate |
| 01/12/2011 | CN201701876U Membrane separating system for extracting bioactive compositions from bamboo leaves |
| 01/12/2011 | CN201701780U Valsartan crystallization-dedicated kettle |
| 01/12/2011 | CN1981817B Chinese-medicinal composition for treating cardiovascular diseases, its preparation and use |
| 01/12/2011 | CN1943781B Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2011 | CN1923229B Pharmaceutical composition comprising notoginseng extract, Danshen extract and puerarin |
| 01/12/2011 | CN1894273B Peptide inhibiting angiotensin converting enzyme |
| 01/12/2011 | CN1883585B Pharmaceutical composition for treating atherosclerosis and method for preparing same |
| 01/12/2011 | CN1872170B Application of medication composition of containing corydalis tuber in preparing medication for treating chronic insufficiency of supplying blood for brain |
| 01/12/2011 | CN1824315B Synergistic therapeutic compositions and methods |
| 01/12/2011 | CN1785251B Powder injection containing red-rooted salvia |
| 01/12/2011 | CN101946003A Anti-adam-15 antibodies and utilization of the same |
| 01/12/2011 | CN101945871A Imidazo [1,2-a] pyridine compounds |
| 01/12/2011 | CN101945659A Adrenomedullin production enhancer |
| 01/12/2011 | CN101942419A Dog parvovirus attenuated vaccine strain and application thereof |
| 01/12/2011 | CN101942012A Polypeptide for preventing and treating angiogenesis and application thereof |
| 01/12/2011 | CN101941999A Method for preparing scutellarin |
| 01/12/2011 | CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry |
| 01/12/2011 | CN101940785A Hydrogen sulfide-producing enzyme preparation and use thereof |
| 01/12/2011 | CN101940778A Medicinal composition for treating heart failure and preparation method and application thereof |
| 01/12/2011 | CN101940767A Vigor-revitalizing and brain-invigorating pill and preparation method thereof |
| 01/12/2011 | CN101940766A Medicine for radically curing myocardial infarction and preparation method thereof |
| 01/12/2011 | CN101940765A Medicament for treating chronic cerebral circulation insufficiency and preparation method |